Company Description
Savient Pharmaceuticals Inc.. The Group's principal activity is to develop, manufacture and market pharmaceutical products for unmet medical needs in both niche and broader markets segments. Its products are distributed worldwide through a direct ...
Related Business Topics
Breaking News
CNBC - November 04, 2009 6:42 PM
Forbes.com - November 04, 2009 5:14 PM
EAST BRUNSWICK, N.J., Nov. 4 /PRNewswire-FirstCall/ -- Savient Pharmaceuticals, Inc. (Nasdaq: SVNT) today reported financial results for the three and nine months ended September 30, 2009, ending the quarter with $67.5 million in cash and short-term ...
Reuters - November 04, 2009 4:59 PM
EAST BRUNSWICK, N.J., Nov. 4 /PRNewswire-FirstCall/ -- Savient Pharmaceuticals, Inc. (Nasdaq: SVNT) today reported financial results for the three and nine months ended September 30, 2009, ending the quarter with $67.5 million in cash and short-term ...
Reuters - October 28, 2009 5:05 PM
EAST BRUNSWICK, N.J., Oct. 28 Savient Pharmaceuticals, Inc. (Nasdaq: SVNT) announced today that the company will release financial results for the third quarter 2009 following the close of the market on Wednesday, November 4, 2009. Paul Hamelin, ...
CNBC - October 28, 2009 5:02 PM
/PRNewswire via COMTEX/ -- EAST BRUNSWICK, N.J., Oct. 28 Savient Pharmaceuticals, Inc. (Nasdaq: SVNT) announced today that the company will release financial results for the third quarter 2009 following the close of the market on Wednesday, November 4, ...
